Your browser doesn't support javascript.
loading
Antiviral agents for COVID-19 / 中华临床感染病杂志
Chinese Journal of Clinical Infectious Diseases ; (6): 92-101, 2020.
Article in Chinese | WPRIM | ID: wpr-869289
ABSTRACT
In December 2019, the endemic of COVID-19 broke out in Wuhan, China. The disease is highly contagious and quickly spreads at home and abroad, causing great concern. However, there are no definite effective antiviral drugs in clinical use. Given the urgency of the COVID-19 outbreak, based on the diagnosis and treatment recommendation and relavant researches, this article describes the optional antiviral drugs such as remdesivir, oseltamivir, arbidol, lopinavir/ritonavir, ribavirin, and interferon-α to provide a reference for treatment of COVID-19.
Full text: Available Index: WPRIM (Western Pacific) Type of study: Practice guideline Language: Chinese Journal: Chinese Journal of Clinical Infectious Diseases Year: 2020 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Type of study: Practice guideline Language: Chinese Journal: Chinese Journal of Clinical Infectious Diseases Year: 2020 Type: Article